Currently out of the existing stock ratings of James Lee, 403 are a BUY (72.09%), 14 are a SELL (2.5%), 142 are a HOLD (25.4%).

James Lee

Work Performance Price Targets & Ratings Chart

Analyst James Lee, carries an average stock price target met ratio of 61.02% that have a potential upside of 40.25% achieved within 165 days. Previously, James Lee worked at MIZUHO.

James Lee’s has documented 1,106 price targets and ratings displayed on 51 stocks. The coverage was on Communication Services, Consumer Cyclical, Healthcare, Technology sectors.

Most recent stock forecast was given on BABA, Alibaba Group Holding Ltd at 16-May-2025.

Wall Street Analyst James Lee

Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%) receiving and performance score of 159.54.

Average potential price target upside

of $401.98 (18.12%) on BKNG (BOOKING HOLDINGS).
of $112.58 (72.78%) on GRUB (GRUBHUB).
of $67.07 (30.27%) on META (META PLATFORMS).

ABNB Airbnb AMZN Amazon.com ARGX argenx NV ADR AXSM Axsome Therapeutics BABA Alibaba Group Holding Ltd BIDU Baidu BKNG Booking Holdings CNCE Concert Pharmaceuticals CPNG Coupang LLC DASH DoorDash Common Stock EBAY eBay EXPE Expedia Group FB Meta Platforms GOOG Alphabet Class C GOOGL Alphabet JD JD.com Adr META Meta Platforms SAGE Sage Therapeutic TCOM Trip.com Group Ltd ADR TRIP TripAdvisor TRVG Trivago NV TWTR Twitter UBER Uber Technologies A Agilent Technologies ADVM Adverum Biotechnologies ANAB AnaptysBio CPRX Catalyst Pharmaceuticals NTLA Intellia Therapeutics GBT Global Blood Therapeutics RARE Ultragenyx MRNS Marinus Pharmaceuticals WVE Wave Life Sciences Ltd CRMD CorMedix EDIT Editas Medicine APTX Aptinyx ARVN Arvinas CRSP Crispr Therapeutics AG CTRP Trip.com Group EBC Eastern Bankshares LJPC La Jolla Pharmaceutical Co PRFT Perficient RLMD Relmada Therapeutics TCEHY Tencent Holdings Ltd ADR TSHA Taysha Gene Therapies VKTX Viking Therapeutics VRNA Verona Pharma PLC ADR CORT Corcept Therapeutics BILI Bilibili DADA Dada Nexus Ltd GRUB GrubHub SABR Sabre Corpo

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Stephen Ju (UBS)